The NHS Diabetes Prevention Programme (NHS DPP) is a joint commitment from NHS England, Public Health England and Diabetes UK to deliver, at scale, evidence based behavioural interventions that can prevent or delay the onset of Type 2 diabetes in adults who have been identified as having non-diabetic hyperglycaemia. This short report uses data collected from GP practices alongside the National Diabetes Audit (NDA) for the period January 2018 to March 2019 inclusive. This report is for England only. Unlike the NDA, it does not include information on Wales.
This short report details the top-level findings for the period 2018-19 audit. It provides an update on information published for the period 2017-18, which can be found here: https://digital.nhs.uk/data-and-information/publications/statistical/national-diabetes-audit/diabetes-prevention-programme-2017-18
Further reporting will follow during 2020.
- Non-diabetic hyperglycaemia refers to blood glucose levels that are above normal but not in the diabetic range (HbA1c 42-47 mmol/mol (6.0-6.4%) or fasting plasma glucose 5.5-6.9 mmol/l).
- People with non-diabetic hyperglycaemia are at increased risk of developing Type 2 diabetes. They are also at increased risk of other cardiovascular conditions.
- 1.8 million people in England were recorded as having non-diabetic hyperglycaemia for the period January 2018 to March 2019. This is an increase from 1.3 million in 2017-18. The difference is almost certainly due to an increase in the recording of the diagnosis during 2018-19, and not an additional 0.5 million people becoming non-diabetic hyperglycaemic.